ArticleBMJ open2026

Risk and benefit for targeted therapy agents in paediatric phase I trials in oncology: a systematic review and meta-analysis protocol.

Joanna Ostrowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.